Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Alcoholic liver disease 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 2 | Alcoholic liver disease 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 3 | Autoimmune thyroid disease 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 4 | Autoimmune thyroid disease 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 5 | Coronavirus disease - COVID-19 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 6 | Coronavirus disease - COVID-19 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 7 | Cytokine-cytokine receptor interaction 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 8 | Cytokine-cytokine receptor interaction 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 9 | Cytosolic DNA-sensing pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 10 | Cytosolic DNA-sensing pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 11 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 12 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 13 | Hepatitis B 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 14 | Hepatitis B 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 15 | Hepatitis C 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 16 | Hepatitis C 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 17 | Herpes simplex virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 18 | Herpes simplex virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 19 | Human cytomegalovirus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 20 | Human cytomegalovirus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 21 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 22 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 23 | Human papillomavirus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 24 | Human papillomavirus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 25 | Influenza A 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 26 | Influenza A 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 27 | JAK-STAT signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 28 | JAK-STAT signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 29 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 30 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 31 | Lipid and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 32 | Lipid and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 33 | Measles 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 34 | Measles 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 35 | Natural killer cell mediated cytotoxicity 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 36 | Natural killer cell mediated cytotoxicity 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 37 | Necroptosis 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 38 | Necroptosis 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 39 | NOD-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 40 | NOD-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 41 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 42 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 43 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 44 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 45 | RIG-I-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 46 | RIG-I-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 47 | Toll-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 48 | Toll-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 49 | Tuberculosis 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 50 | Tuberculosis 💬 1 gene, 2 drugs (DrugBank) and 1 disease |
IFNA5 1件: IFNA5 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|